HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation

Published:2016-12-30 Issue:2 Volume:40 Page:133-144
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Bugide Suresh,Gonugunta Vijay Kumar,Penugurti Vasudevarao,Malisetty Vijaya Lakshmi,Vadlamudi Ratna K.,Manavathi Bramanandam

Funder

Department of Biotechnology , Ministry of Science and Technology

Science and Engineering Research Board

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13402-016-0308-2.pdf

Reference57 articles.

1. R.P. Perez, A.K. Godwin, T.C. Hamilton, R.F. Ozols, Ovarian cancer biology. Semin Oncol 18, 186–204 (1991)

2. K.R. Cho, M. Shih Ie, Ovarian cancer. Ann Rev Pathol 4, 287–313 (2009). doi: 10.1146/annurev.pathol.4.110807.092246

3. T.A. Yap, C.P. Carden, S.B. Kaye, Beyond chemotherapy: targeted therapies in ovarian cancer. Nat Rev Cancer 9, 167–181 (2009). doi: 10.1038/nrc2583

4. N. Colombo, T. Van Gorp, G. Parma, F. Amant, G. Gatta, C. Sessa, I. Vergote, Ovarian cancer. Crit Rev Oncol Hematol 60, 159–179 (2006). doi: 10.1016/j.critrevonc.2006.03.004

5. S. Patel, L. Kumar, N. Singh, Metformin and epithelial ovarian cancer therapeutics. Cell Oncol 38, 365–375 (2015). doi: 10.1007/s13402-015-0235-7

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GCNT3 Promotes Hepatocellular Carcinoma Progression and EMT by Activating the PI3K/AKT Pathway;Biochemical Genetics;2024-05-24

2. Metformin Mechanism of Inhibiting PI3K/mTOR through CCNB1 and Affecting Epithelial-Mesenchymal Transition in Ovarian Cancer Cells;J BIOL REG HOMEOS AG;2024

3. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes;Molecular Cancer;2024-01-22

4. HPIP and RUFY3 are noncanonical guanine nucleotide exchange factors of Rab5 to regulate endocytosis-coupled focal adhesion turnover;Journal of Biological Chemistry;2023-11

5. Drug resistance and immunotherapy in gynecologic cancers;Life Sciences;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3